Lung Cancer Spotlight-Diagnostic Lung Cancer Evaluation: Tissue Sampling, Imaging & Blood Based Molecular Profiling

Diagnostic Lung Cancer Evaluation: Tissue Sampling, Imaging & Blood Based Molecular Profiling

Video Transcription

Video Summary

The video transcript discusses the importance of lung cancer diagnosis and staging. The presenter emphasizes the need for accurate staging in order to determine the most appropriate treatment for patients. Various methods of staging, such as endobronchial ultrasound and PET-CT scans, are discussed, with a focus on the advantages of invasive staging procedures like EBUS and EUS over non-invasive methods like PET-CT alone. The presenter also highlights the significance of biopsy specimens, especially in small lesions, as they can provide crucial information for accurate diagnosis and determination of disease stage. The potential role of blood-based biomarker testing, particularly for non-small cell lung cancer, is also discussed. The presenter emphasizes the need for widespread adoption of biomarker testing and improved access to enable more patients to benefit from targeted therapies. The transcript concludes by reviewing studies that examine current practice patterns and the challenges in implementing NGS testing for lung cancer patients. The need for ongoing improvement in both lung cancer staging and biomarker testing is highlighted.

Meta Tag

Category Lung Cancer

Speaker Erik Folch, MD, MS

Speaker Catherine Oberg, MD

Speaker Raymond Osarogiagbon, MD

Keywords

lung cancer diagnosis

accurate staging

invasive staging procedures

EBUS

EUS

biopsy specimens

blood-based biomarker testing

targeted therapies

NGS testing